Rhythm Pharmaceuticals Reports Second Quarter 2022 Financial Results and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Rhythm Pharmaceuticals Reports Second Quarter 2022 Financial Results and Business Update

Rhythm Pharmaceuticals (RYTM) Tops Q2 EPS by 7c

August 2, 2022 7:14 AM EDT

Rhythm Pharmaceuticals (NASDAQ: RYTM) reported Q2 EPS of ($0.89), $0.07 better than the analyst estimate of ($0.96). Revenue for the quarter came in at $9.07 million versus the consensus estimate of $2.57 million.

For earnings history and earnings-related data on Rhythm Pharmaceuticals (RYTM) click here.

... More